The field is growing across the spectrum, but the number of individuals needed to meet the demand is not expanding at the same pace. We need innovative ways to showcase nuclear medicine as a profession.

In addition, we continue to see issues related to inadequate coding, inconsistent or unclear pricing structures, and billing processes that can be fragmented and difficult to navigate. Those barriers create uncertainty, not only for providers but also for health systems trying to build sustainable programs and for patients trying to access care. If we want these innovations to reach more people, reimbursement policy must evolve alongside the science. That means clearer coding pathways, better alignment between coverage and clinical value, and a more practical framework for institutions that are investing in these services. Neither is a small challenge, but both are essential to address if we want the field to continue growing responsibly.


HCB News: What advice would you give to attendees of this year’s annual meeting?
HJ: My biggest advice is to be intentional, because there is an incredible amount of content at this year’s annual meeting, and no one can realistically do everything. Start by planning your days in advance and using the available web-based resources strategically, so you can prioritize the sessions and experiences that are most valuable to attend in person. I would especially highlight the ASCO Live “Intersection” session, moderated by Dr. Michael Hofman and me, which brings the most important radiopharmaceutical therapy and molecular imaging updates from the ASCO Annual Meeting directly to attendees in a fast-paced, high-yield format. I’d also strongly encourage attendees to spend time at the revamped Knowledge Bowl, the Young Investigators sessions, and in the Science Pavilion. Those are often some of the best opportunities to exchange ideas, see emerging research, ask questions directly, and make meaningful connections with colleagues and authors. Overall, the best way to maximize the meeting is to focus on what is uniquely valuable in a live setting: the interaction, the discussion, and the networking.

Back to HCB News

Molecular Imaging Homepage